Not known Factual Statements About AZ-23
Not known Factual Statements About AZ-23
Blog Article
quinupristin/dalfopristin will improve the degree or result of lemborexant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Stay away from coadministration of lemborexant with reasonable or powerful CYP3A inhibitors.
Antibiotics which include quinupristin and dalfopristin injection will likely not do the job for colds, flu, or other viral bacterial infections. Having or working with antibiotics when they are not required increases your threat of acquiring an an infection later on that resists antibiotic remedy.
quinupristin/dalfopristin will improve the amount or influence of cortisone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
quinupristin/dalfopristin will enhance the degree or result of cyclosporine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
quinupristin/dalfopristin will improve the amount or effect of tolterodine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
quinupristin/dalfopristin will increase the amount or effect of tezacaftor by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Closely. Adjust tezacaftor dosage program if coadministered with a average CYP3A inhibitor.
convey to your health practitioner and pharmacist In case you are allergic to quinupristin and dalfopristin, other streptogramin antibiotics, another prescription drugs, or any from the components in quinupristin and dalfopristin injection. Check with your pharmacist for a list of the ingredients.
quinupristin/dalfopristin will boost the degree or impact of fosaprepitant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
Keep an eye on Carefully (1)quinupristin/dalfopristin will raise the degree or effect of digoxin by altering intestinal flora. Applies only to oral form of the two agents. Use Warning/Monitor.
Use Caution/Watch. Coadministration with antibiotics decreases efficacy by altering colonic bacterial flora desired to transform sodium picosulfate to Lively drug.
quinupristin/dalfopristin will raise the amount or result of ziprasidone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unidentified.
quinupristin/dalfopristin will raise the degree or result of cannabidiol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. DO-264 Modify Therapy/Monitor Intently. Consider decreasing the cannabidiol dose when coadministered using a moderate CYP3A4 inhibitor.
As well as its wanted outcomes, a medication may possibly bring about some undesired outcomes. Though not all of these Negative effects could arise, when they do take place they may require healthcare interest.
quinupristin/dalfopristin will enhance the stage or influence of iloperidone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.